Midazolam Hydrochloride
Sponsors
Heidelberg University Hospital AöR, Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI), Boehringer Ingelheim, Daiichi Sankyo
Conditions
Adult Solid NeoplasmAdvanced Solid TumorAlcohol Use DisorderAmnesia-Memory LossAnesthesiaAnesthesia ComplicationAtopic DermatitisBipolar Depression
Phase 1
Effect of Affective Content on Drug Induced Amnesia of Episodic Memory
CompletedNCT00142493
Start: 2004-09-30End: 2008-08-31Updated: 2015-12-24
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors
CompletedNCT01218620
Start: 2010-09-30End: 2014-12-31Updated: 2014-12-23
Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers
CompletedNCT02256813
Start: 2005-09-30Updated: 2014-10-06
A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS
CompletedNCT02473627
Start: 2015-05-31End: 2015-07-31Updated: 2015-11-05
Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients
CompletedNCT03330990
Start: 2017-11-14End: 2018-07-11Updated: 2018-08-21
Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s
CompletedNCT03457597
Start: 2018-03-06End: 2018-04-28Updated: 2018-05-17
Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
CompletedNCT03556592
Start: 2018-08-13End: 2020-06-20Updated: 2025-02-24
Ketamine for Combined Depression and Alcohol Use Disorder
Not yet recruitingNCT06090422
Start: 2025-01-01End: 2027-07-01Target: 34Updated: 2024-09-19
Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery
CompletedNCT06867068
Start: 2016-10-04End: 2024-06-10Updated: 2026-03-27
Phase 2
Investigation of Antidepressant Efficacy of Oral Ketamine Treatment
NCT02992496
Start: 2017-04-24End: 2020-12-31Target: 60Updated: 2019-09-03
Ketamine for Treatment-Resistant Bipolar Disorder
CompletedNCT05004896
Start: 2022-07-04End: 2025-11-14Updated: 2026-03-05
Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT)
RecruitingCTIS2022-502332-39-00
Start: 2023-11-15Target: 64Updated: 2025-08-25
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
RecruitingNCT06480500
Start: 2024-01-02End: 2026-06-30Target: 110Updated: 2025-12-05
Ketamine for Methamphetamine Use Disorder
RecruitingNCT06496750
Start: 2024-09-11End: 2026-10-15Target: 120Updated: 2026-04-01